Ubs Group Ag Pear Therapeutics, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $1.24 $5,229 - $30,876	24,900 Added 155.72%	40,890 $10,000
Q4 2022 Feb 08, 2023	BUY	$0.99 - $2.91 $15,830 - $46,530	15,990 New	15,990 $18,000
Q2 2022 Aug 10, 2022	SELL	$1.54 - $6.48 $5,069 - $21,332	-3,292 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.67 - $7.63 $3,952 - $8,217	-1,077 Reduced 24.65%	3,292 $17,000
Q4 2021 Feb 14, 2022	BUY	$4.98 - $10.0 $21,757 - $43,690	4,369 New	4,369 $27,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.